Active, Not Recruiting
A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation
NCT03182244
- Conditions
- AML With FLT3 Mutation, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Site CN103 Beijing, China
- Site CN108 Beijing, China
- Site CN109 Beijing, China
- Site CN110 Beijing, China